A detailed history of Commonwealth Equity Services, LLC transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 13,362 shares of PRPH stock, worth $30,331. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,362
Previous 13,362 -0.0%
Holding current value
$30,331
Previous $56,000 42.86%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$4.18 - $7.35 $6,270 - $11,025
-1,500 Reduced 10.09%
13,362 $56,000
Q1 2024

Apr 29, 2024

SELL
$4.47 - $6.47 $5,207 - $7,537
-1,165 Reduced 7.27%
14,862 $96,000
Q4 2023

Feb 06, 2024

SELL
$4.35 - $5.1 $10,005 - $11,730
-2,300 Reduced 12.55%
16,027 $72,000
Q3 2022

Nov 14, 2022

BUY
$8.96 - $14.7 $6,845 - $11,230
764 Added 4.35%
18,327 $206,000
Q2 2022

Jul 19, 2022

SELL
$6.52 - $13.24 $13,613 - $27,645
-2,088 Reduced 10.63%
17,563 $222,000
Q1 2022

May 04, 2022

BUY
$6.2 - $7.87 $4,867 - $6,177
785 Added 4.16%
19,651 $137,000
Q2 2021

Aug 11, 2021

BUY
$4.61 - $6.83 $4,287 - $6,351
930 Added 5.19%
18,866 $116,000
Q4 2020

Feb 11, 2021

BUY
$3.9 - $11.25 $3,900 - $11,250
1,000 Added 5.9%
17,936 $164,000
Q3 2020

Nov 05, 2020

SELL
$1.4 - $3.87 $1,400 - $3,870
-1,000 Reduced 5.58%
16,936 $58,000
Q4 2019

Feb 05, 2020

BUY
$1.66 - $2.2 $2,757 - $3,654
1,661 Added 10.21%
17,936 $35,000
Q2 2019

Jul 19, 2019

BUY
$2.1 - $3.07 $4,200 - $6,140
2,000 Added 14.01%
16,275 $34,000
Q1 2019

May 13, 2019

BUY
$2.7 - $3.65 $2,875 - $3,887
1,065 Added 8.06%
14,275 $42,000
Q3 2018

Nov 06, 2018

SELL
$2.94 - $3.23 $2 - $3
-1 Reduced 0.01%
13,210 $39,000
Q2 2018

Jul 31, 2018

BUY
$2.84 - $5.41 $9,119 - $17,371
3,211 Added 32.11%
13,211 $43,000
Q4 2017

Feb 12, 2018

BUY
$2.05 - $2.3 $20,500 - $23,000
10,000
10,000 $22,000

Others Institutions Holding PRPH

About ProPhase Labs, Inc.


  • Ticker PRPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 16,024,400
  • Market Cap $36.4M
  • Description
  • ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...
More about PRPH
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.